首页> 美国卫生研究院文献>Stem Cell Research Therapy >Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)
【2h】

Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)

机译:心脏再生中的间充质干细胞:最近6年(2010-2015年)的详细进展报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cells have been used for cardiovascular regenerative therapy for decades. These cells have been established as one of the potential therapeutic agents, following several tests in animal models and clinical trials. In the process, various sources of mesenchymal stem cells have been identified which help in cardiac regeneration by either revitalizing the cardiac stem cells or revascularizing the arteries and veins of the heart. Although mesenchymal cell therapy has achieved considerable admiration, some challenges still remain that need to be overcome in order to establish it as a successful technique. This in-depth review is an attempt to summarize the major sources of mesenchymal stem cells involved in myocardial regeneration, the significant mechanisms involved in the process with a focus on studies (human and animal) conducted in the last 6 years and the challenges that remain to be addressed.Electronic supplementary materialThe online version of this article (doi:10.1186/s13287-016-0341-0) contains supplementary material, which is available to authorized users.
机译:间充质干细胞已经用于心血管再生治疗数十年。经过在动物模型和临床试验中的几次测试,这些细胞已被确立为潜在的治疗剂之一。在此过程中,已经鉴定出各种来源的间充质干细胞,它们可以通过使心脏干细胞恢复活力或使心脏的动脉和静脉血管再生来帮助心脏再生。尽管间充质细胞疗法已经获得了令人钦佩的赞赏,但是仍然存在一些需要克服的挑战,以使其成为成功的技术。这项深入的综述旨在总结参与心肌再生的间充质干细胞的主要来源,该过程涉及的重要机制,重点是过去六年进行的研究(人类和动物)以及仍然存在的挑战电子补充材料本文的在线版本(doi:10.1186 / s13287-016-0341-0)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号